🇺🇸 FDA
Patent

US 11285169

Methods for modulating chemotherapeutic cytotoxicity

granted A61KA61K31/137A61K31/351

Quick answer

US patent 11285169 (Methods for modulating chemotherapeutic cytotoxicity) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/137, A61K31/351, A61K31/365, A61K31/437